Medicare
-
Medicare Part D Cap Rise to $2,400 Outweighs 2027 Ozempic Price Cuts
Patients relying on maintenance drugs like Ozempic face higher annual spending caps in 2027 despite new Medicare price negotiations.
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
Despite FDA advisory support, CMS excludes Galleri from coverage, forcing patients to pay out-of-pocket while awaiting a 2029 policy shift.
-
Why Insurers Send Their Own Nurses to Deny Long-Term Care Claims
After 23 years of premiums, a policyholder’s doctor confirmed she needed help bathing and dressing, but an insurer’s nurse scored her as…
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
How a $310,000 Investment Gain Can Boost Medicare Premiums for Retirees
A retiree’s capital gains from selling investments can trigger higher Medicare Part B premiums two years later, a surprise cost many overlook.
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
Missing paperwork accounts for 85.5% of improper Medicare payments for diabetic shoes, highlighting strict compliance hurdles for patients and providers.
-
Medicare Advantage Agents Earn Up to $725 per Enrollment While Original Medicare Pays Nothing
Federal caps allow agents to earn hundreds for Medicare Advantage sign-ups while paying nothing for Original Medicare recommendations.
-
The Growing Financial and Regulatory Realities of Concierge Medicine Models
As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.
-
AHA-Kaufman Hall Report Urges Broader Review of Hospital Mergers
CHICAGO, September 16 — Nearly 60% of hospital patient days in the United States are attributable to Medicare, Medicaid and Medicare Advantage…
-
Harvard Economist Kenneth Rogoff Warns a U.S. Debt Reckoning Will Fall on Higher Earners
WASHINGTON, August 29 — Harvard economist Kenneth Rogoff warned that America’s expanding fiscal deficits will inevitably force a debt reckoning that hits…
-
CBO and Trustees Differ on When Social Security Trust Funds Run Dry, 2032 or 2033
WASHINGTON, July 19 — The Social Security program’s financial foundation is built on a ticking clock. Without legislative action before 2033, the…
-
Interest on federal debt now tops defense and Medicare spending, House Budget Committee says
WASHINGTON — The Congressional Budget Office’s long-term budget outlook, released in February 2024, painted a stark picture of the nation’s fiscal trajectory.…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992